Back to SUSQUEHANNA INTERNATIONAL GROUP, LLP SUSQUEHANNA INTERNATIONAL GROUP, LLP

SPROSPRO
Showing 8 of 27 quarters

Position history for SUSQUEHANNA INTERNATIONAL GROUP, LLPSUSQUEHANNA INTERNATIONAL GROUP, LLP's holdings in SPERO THERAPEUTICS INC

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds 759,290 shares of SPRO (SPERO THERAPEUTICS INC), worth $1.7M as of 2026-Q2. The position was increased (+127.9% shares). SPRO represents 0.0% of SUSQUEHANNA INTERNATIONAL GROUP, LLP's portfolio.

Current Value

$1.7M

Current Shares

759,290

Total Value Change

+$1.6M

Total Shares Change

+715,071

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
759,290
+127.9%
$1.7M0.0%$2.21
41
2026-Q1
Increased
333,115
+13.4%
$779,4890.0%$2.19
28
2025-Q4
New
293,700
-
$684,3210.0%$2.27
34
2025-Q3
Exited
0
-100.0%
$00.0%$1.90
0
2025-Q2
New
69,814
-
$202,4610.0%$2.94
35
2025-Q1
Exited
0
-100.0%
$00.0%$0.77
0
2024-Q4
Decreased
29,755
-32.7%
$30,6480.0%$1.02
0
2024-Q3
Increased
44,219
+91.7%
$59,2530.0%$1.31
22

Other major holders of SPRO: BNP PARIBAS FINANCIAL MARKETS, Steward Partners Investment Advisory, LLC, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used